Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2670207rdf:typepubmed:Citationlld:pubmed
pubmed-article:2670207lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:2670207lifeskim:mentionsumls-concept:C0278678lld:lifeskim
pubmed-article:2670207lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2670207lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:2670207pubmed:dateCreated1989-9-27lld:pubmed
pubmed-article:2670207pubmed:languageenglld:pubmed
pubmed-article:2670207pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2670207pubmed:citationSubsetIMlld:pubmed
pubmed-article:2670207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2670207pubmed:statusMEDLINElld:pubmed
pubmed-article:2670207pubmed:monthJunlld:pubmed
pubmed-article:2670207pubmed:issn0305-7372lld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:IsraelLLlld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:RugarliCClld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:FossåS DSDlld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:FranksC RCRlld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:JasminCClld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:StoterGGlld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:PhilipTTlld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:SymannMMlld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:PalmerPPlld:pubmed
pubmed-article:2670207pubmed:authorpubmed-author:BijmanJ TJTlld:pubmed
pubmed-article:2670207pubmed:issnTypePrintlld:pubmed
pubmed-article:2670207pubmed:volume16 Suppl Alld:pubmed
pubmed-article:2670207pubmed:ownerNLMlld:pubmed
pubmed-article:2670207pubmed:authorsCompleteYlld:pubmed
pubmed-article:2670207pubmed:pagination111-3lld:pubmed
pubmed-article:2670207pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:meshHeadingpubmed-meshheading:2670207-...lld:pubmed
pubmed-article:2670207pubmed:year1989lld:pubmed
pubmed-article:2670207pubmed:articleTitleMetastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study.lld:pubmed
pubmed-article:2670207pubmed:affiliationRotterdam Cancer Institute, The Netherlands.lld:pubmed
pubmed-article:2670207pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2670207pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2670207pubmed:publicationTypeMulticenter Studylld:pubmed